April 11, 2007

In This Issue

Search the website:

Message Boards

• Robin writes: Getting "Flakey" in a geeky way, Research, bookmarks, and general info to share

Cushing's:

• Equine Cushing's Drug Pergolide to be Withdrawn for Human Use

• FDA Announces Voluntary Withdrawal of Pergolide Products
Agency Working with Product Manufacturers


• NIH Clinical Trials, 10 studies were found for Cushing's.

Adrenal:

• Disease Underlies Hatfield-McCoy Feud

• NIH Clinical Trials.  90 Adrenal Studies

Pituitary:

NIH.  85 Pituitary Clinical Trials
 


US Postage Stamps for Cushing's Awareness

Order Cushing's Awareness Silicone Bands for yourself, a family member or donate to a Cushing's patient at NIH

Upcoming Meetings: Washington, DC and Toronto ENDO 2007.


Also on the website:

April 8, 2007, Petitions on the message boards to have April 8 be declared as Cushing's Awareness Day again this year. This date was chosen because it was Dr. Harvey Cushing's Birthday. More info here »

 Pictures from Past Meetings:

Pictures from the Pittsburgh, PA Christmas Dinner, December 13, 2006
Click here »

Pictures from the April 5-8, 2006 CUSH Cushing's Awareness Day Medical Forum, held in Oklahoma City, OK
Click here »

Upcoming Meetings:
June 2-5, 2007, ENDO 2007, Toronto, Canada, Metro Toronto Center.

October 6, 2007, Rockford, IL lunch. more info as it becomes available

Recent Donations:

click for fullsize graph

• In honor of:
   Dr. Jennifer Pecina
Other donors
To make a donation
Donations cover...

News:

Dr. Theodore Friedman from Charles R. Drew University, Division of Endocrinology is currently seeking patients to participate in a research study of pituitary dysfunction. More info.

• The message boards now number over 6,000 participants.

Search Tool. Use this tool to search this site, PubMed, NIH Clinical Trials or any other website. More sites to be added soon.

CUSH Cuisine! $10.00 each, including shipping.
More info »

Guest Transcripts »

Latest Media:

Sam who has been on The Mystery Diagnosis TV Show (Discovery Health) has been invited to appear on Dr. Phil taping soon. More info as it becomes available.

Helpful Books (pituitary):
Art Russell shares the powerful story of his struggle with Cushing's Disease.

October 18, 2006 Obese from Secret Disease (ABC News) (Jaimie on the boards) Read this article »

Jun 17, 2006 Student hopes to rebound from brain surgery Rare disease caused teen to double weight in a year Read this article »

May 21, 2006 Rare disease treated at OHSU (sowens on the boards) Read this article »

May 15, 2006 Patients Fighting Cushings Disease (Rooon on the boards)
Read this article »

MedScape News

Newest Site Features:
Read the Current Newsletter »

Packing Suggestions For Surgery

Talk to Your Doctor

Corticosteroid Converter.

More info on Adrenal Crisis.

Helpful Hints for dealing with Cushing's Symptoms. The first ones are here.

Add your Helpful Hints

US Cushing's Postage Stamps to promote Cushing's Awareness. See a sample here.

Cushing's Bracelets to promote Cushing's Awareness. Order the bands here.

Reviews of this site

Testing:
Midnight Salivary Cortisol Versus Urinary Free and Midnight Serum Cortisol

Videos and Webcasts:
Video: Transnasal Pituitary Surgery

Webcasts from NIH Pituitary Symposium and Endo 2004.

Videos on several topics of interest to Cushing's Patients:

Jaimie and others from the message boards on TV

Transsphenoidal Pituitary Surgery

Laparoscopic Bilateral Adrenalectomy (BLA)

Transsphenoidal Pituitary Surgery

A Young Woman's Battle with a Hidden Enemy: Cushing's Disease

Top Five Webcast feature updates twice daily and highlights the most popular webcasts viewed each day.

New pages and updates

Doctors and Hospitals:
The US Helpful Hospitals list has been updated

Helpful Doctors:

US:
Boston, MA
Wichita, KS
Las Cruces, NM
Riviera Beach, FL
Atlanta, GA
East Setauket, NY
Erie, PA
Astoria, OR
Portland, OR

International:
Montréal, Canada
Toronto, Ontario, Canada
Lucknow, India
Moorooka, Queensland, Australia
Budapest, Hungary

Doctors updated:
Dr William Ludlam after his move to Seattle, WA from Portland, OR.
Dr. Blevins is leaving Vanderbilt Hospital to accept a position as Medical Director of the California Center for Pituitary Disorders at UCSF in California beginning May 1, 2007.
Dr Maria Fleseriu, Oregon Health and Science University
Dr. Roberto Salvatori, Johns Hopkins, Baltimore, MD
More info here
Dr. James Neifing, Portland, OR

Newest Bios:
There are currently over 740 bios on the website.
See them all by clicking here.

Add or Update your bio here
Newest bios,
listed by type of Cushing's
Kay
Cindi
Lindsay
Sandra
Renae
Erica
Peggy
Iona
Laura
Kristina
Kim
Krista
Mary
Pat
Leslie

Updated Bios:
Newly updated bios, listed by type of Cushing's
Cathy Tia
Judi
Heike
Roxanne
Jen S
Dawnell
Cathy Tia
Ann
Elise
Jessica M
MaryO

In Memory

(Alena) Renea Weeks Greenhill

Sue Ann Koziol (SuziQ),
CUSH Founding President

Sue was a very special friend to Cushies world-wide. We will remember her always.

• To light a candle or post a tribute for Sue, please click here

• To read Sue's bio, please click here

• To read more about Sue's journey with cancer, please click here


Welcome to the Cushing's Help and Support Newsletters!

If it appears that the entire newsletter is not here, or you prefer to read the HTML version of this newsletter on the Internet, it is available here:
http://www.cushingsonline.com/newsletters/4-11-2007.htm.


Read archived past newsletters here: http://www.cushingsonline.com/newsletters/
newsletters.htm

To make sure you continue to receive Cushing's e-mail in your inbox (and that it is not sent to bulk or junk folders), please add CushingsSupport@aol.com to your address book.

Unsubscribe information appears at the bottom of this, and every, newsletter.

Cushing's Awareness Day! April 8, 2007


What Can *YOU* Do to help?

Click on the image of the Senate Resolution 127 (2007) below to view fullsize:



Or Download the Senate Resolution 127 (2007) PDF file.


It's official, the Senate Resolution 127 passed last night making April 8th, 2007 National Cushing's Awareness Day. Let your newsmedia know!

PS, and if you can find Sen. Jim Inhofe's e-mail address (I am late for work and don't have it immediately avail) please tell them how much we appreciate their efforts. He's the US Senator for Oklahoma.

Thanks, Cheryl Farrar
CUSH Vice President

• From Rebecca Sibley

I just wanted you to know that this is the response from one of our house of representatives in SC and that is a going to co-sponsor the house bill for Cushing's Awareness Day!!  My letter to him is below too.  I have tried to get this in our paper too but so far they won't do it.  I sent it in to the state paper and I know they have at least opened it but have no idea if they will print it or not.  I will update them that Rep Bob Inglis will be a co-sponser so that might make the news!
Thanks,
Rebecca Sibley

Rebecca,

Thank you for bringing this to my attention.  You are the first contact I've had on this topic. I'm so sorry to hear how you have suffered with this, and I pray that you are continuing to get relief.

By copy of this note, I'm asking Philip Van Steenburgh of my office to sign me up as a co-sponsor of the House bill.

Blessings,

Bob


http://communitytalk.rd.com/WebX?14@927.FmRaaDQgM3K.0@.feb9f0b/45

From Reader's Digest:


Have a question about heart health? Ask Dr. Mehmet C Oz!
Dr. Oz is a world-renowned heart surgeon at New York-Presbyterian Hospital, Reader's Digest columnist, and vice-chair and professor of surgery at Columbia University. He will be answering your questions in a LIVE CHAT on Thursday, March 22 at 2 p.m. EST.

Send in your questions today and visit rd.com/chat on March 22 to read Dr. Oz's answers.

Read the monthly Reader's Digest column, "Health IQ", by Dr. Oz and Dr. Michael Roizen for more tips on feeling your best.

JayneK asked:   Wed 03/21/07, 12:12:49

National Cushing's Awareness Day is April 8. How is the heart affected by having Cushing's Syndrome/Disease? What can be done to strengthen the heart muscle when surviving Cushing's?

Sign Amber's Petition. www.ipetitions.com/petition/CushingsDiseaseAwareness

Amber writes:

Thought I would explain what this petition can do....

First of all, it adds power and substance to our efforts to have a Nationally recognized day if we have an extensive, following.

Second, this petition and all the signatures can be printed and sent to a Senator, politician, or medical professional that may be will to take on the cause.

Third, this petition and its list of signatures are IDEAL for releasing to the press and media for coverage and will assist GREATLY in getting the word out there.

It is so simple. The petition has a place to add your name and a comment if you want. PLEASE take a moment to sign and formward it on to all the people in your address book, your friends and family.

We all get forwarded messages all the time, but this one is dear to our hearts and can make a differnce! WHATS STOPPING YOU!?

PLEASE SUPPORT OUT EFFORTS TO RAISE AWARENESS! YOUR HELP IS NEEDED AND IT IS SO EASY!

CherylF, CUSH Vice President suggests:
I contacted Senator Inhofe's (OK) office recently, and he is happy to reintroduce the Cushings Awareness Day Resolution for April 8, 2007.

Please contact your US Senator's office and ask them to support this Resolution. I'm not sure when Senator Inhofe will try and contact other senators but if you send a letter soon, and call your senator to let him know your letter is coming, and that Senator Inhofe is going to reintroduce the Resolution, it will truly help.

Last year the Resolution was introduced, but to my understanding, only one senator-another from Oklahoma was the only one to contact Senator Inhofe's (Okla) office to co-sponsor the Resolution.

If you send a letter requesting it, you might also request that a reply be sent back to you . Please try to send the letter in the next two weeks if possible.

Last year we had a small Conference in OKC celebrating the passing of the Resolution, and there is some information on that conference on the CUSH website (CUSH.org) , and I believe on this one as well. We won't be having a specific conference in OKC, but ask that you bring awareness in your own states, communities as you can. Last year a TV station in OKC aired a small segment about the conference & Cushings Awareness Day, as did one in Nebraska- with Autumn as the contact person.

As the OK CUSH rep as well, I might have something for those around the OK area, a small get together if anyone is interested...more like a dinner or luncheon so we can visit each other. You can always contact me for more info if you'd like...together we can make a difference!

cheryl1957ann@sbcglobal.net
Thank you in advance, Cheryl Farrar- CUSH Vice President

Contact your Senator Print out a sample letter to send to your congress person or senator or download it in Word format.

More information here

Follow Jayne's Lead. She writes:

Of course, I'll be supporting the day and writing letters and emails and making phone calls. I hope to find us a celebrity ribbon wearer. Something else I am working on is national TV recognition with the major networks and National publications. You can email them as well on their "contact us" info. Contact the hosts of the show and the producers to mention April 8th and Cushing's Awareness.

I am going to find out information on getting money (grant) to publish magazine adds/articles for the April editions, if not this year then for next year. I know they are probably being printed, but I just thought of this idea. My local paper will run a small 2x3 ad for starting at $300. I want the whole page! I thought about having a yard sale to raise money to put in an ad, but doubt that I'd make enough. Oh Well!

Something else I thought about is getting a chain pharmacy to post cushings info for that week prior to the 8th. Medical school journal/papers can also be contacted. I know I must have emails over 100 doctors last year on the 7th (once I know that it had passed). I'll be setting up a booth at the women's Forum again this year. I hope to set up at some health expo's and at the local Hospital or at least make/pass out flyers.

US Cushing's Postage Stamps to promote Cushing's Awareness. See a sample here.

• Wear Cushing's Bracelets or T-Shirts to promote Cushing's Awareness. Order the bands here.. Cushing's Awareness T-Shirts and other products are available here: Cushie GiftStore.

Post your ideas and what you have done here: http://cushings.invisionzone.com/index.php?showtopic=19173


Last year:

For Immediate Release:                                                                   

                    April 6, 2006                                                                                                          

INHOFE DESIGNATES ‘NATIONAL
CUSHING’S SYNDROME AWARENESS DAY

More info here


April 8, 2006, the Cushing's Understanding, Support & Help Organization (CUSH) petitioned in the USA to have April 8 be declared as Cushing's Awareness Day. This date was chosen because it was Dr. Harvey Cushing's Birthday. More info here


The Cushing's Awareness Day Proclamation, from http://thomas.loc.gov/cgi-bin/query/z?c109:S.RES.423:

Designating April 8, 2006, as `National Cushing's Syndrome Awareness Day'. (Agreed to by Senate)

More info here

 

Dr. Theodore Friedman from Charles R. Drew University, Division of Endocrinology is currently seeking patients to participate in a research study of pituitary dysfunction. More info.


On the Message Boards

Robin writes: Getting "Flakey" in a geeky way, Research, bookmarks, and general info to share

I've been having a lot of fun "flaking"..... I'm exploring the new Web 2.0 technologies which include wiki's, podcasts, newsfeeds, and flakes.....

I've built a flake for Cushing's to share what info I have with anyone who wants to use it. I'm still working on it and have a lot more to add, but I'll do it as I can. A lot of things I've put there point back to this site, and if it's a link to the boards, only board members will be able to see it.

http://www.pageflakes.com/staticnrg.ashx?

I've put a feed of my bookmarks on the flake site, but I also have another public site for them, too:

http://del.icio.us/staticnrg

The neat thing about all this is you can do this, too, and we can "network", sharing with each other. You can incorporate my stuff in to your flake, and I can incorporate yours. It's a way for us to share info with each other. MaryO may want to put links to all this on here...I don't know. But it's the "new" thang, and predicted to be how things are going.


Updated Pages on the Website:

Testimonials http://www.cushings-help.com/testimonials.htm

This site helped me through a very difficult time in my life and has been an ongoing source of education and support as I have continued healing and learning about my body functions

From Roxanne's bio


News Items:

Media:

• Sam who has been on The Mystery Diagnosis TV Show (Discovery Health) has been invited to appear on Dr. Phil taping soon. More info as it becomes available.


Cushing's:

• From http://www.thehorse.com/ViewArticle.aspx?ID=9317

Equine Cushing's Drug Pergolide to be Withdrawn for Human Use
by: Erin Ryder, News Editor
April 04 2007
Article # 9317

The FDA has announced pergolide is to be voluntarily withdrawn for human use. Pergolide is commonly used for horses with pituitary pars intermedia dysfunction (PPID), also known as equine Cushing's disease.

According to the FDA announcement, all pergolide products (Permax and two generic formulas) will be withdrawn for human use. Pergolide has been used as a treatment for Parkinson's disease. Concerns about the serious risk of damage to patients' heart valves led to the withdrawal.

Barbara D. Forney, MS, VMD, noted in the 2007 revised edition of Understanding Equine Medications that no information could be found on side effects of pergolide in horses.

Regarding the withdrawal, Forney said some other drugs removed from the human market in the past are now available for veterinary use via compounding pharmacies.

Forney said she doesn't anticipate a major change in the availability of the drug for equine use.

"The reality of it is that most of the horses that are on pergolide are already using a compounded product because of the way the drug is dosed and economics, so it probably won't change much," Forney stated. "But it does highlight why ethical compounding is really important to veterinarians."

FDA Department of Public Affairs spokesperson Sandy Walsh said the manufacturers could also make the drug directly available for veterinary use.

"Pergolide is not an approved animal drug," Walsh said. "As for deciding whether or not the product will be available for vet use, it depends on the company. If they want to make it available for animal use, that is their prerogative."

Walsh noted three other dopamine agonists without the same risk of side effects are available for human patients.

To read the FDA withdrawal notice click here or see below.


FOR IMMEDIATE RELEASE
P07-54
March 29, 2007

Media Inquiries:
Sandy Walsh, 301-827-6242

Consumer Inquiries:
888-INFO-FDA

FDA Announces Voluntary Withdrawal of Pergolide Products
Agency Working with Product Manufacturers

 

The U.S. Food and Drug Administration (FDA) today announced that manufacturers of pergolide drug products, which are used to treat Parkinson’s disease, will voluntarily remove these drugs from the market because of the risk of serious damage to patients’ heart valves.

The products being withdrawn are Permax, the trade name for pergolide marketed by Valeant Pharmaceuticals, and two generic versions of pergolide manufactured by Par and Teva. Pergolide is in a class of medications called dopamine agonists and is used with levodopa and carbidopa to manage the symptoms (tremors and slowness of movement) of Parkinson’s disease.

In 2006, an estimated 12,000 patients received prescriptions for pergolide from retail pharmacies in the United States. Patients taking pergolide should contact their doctors to discuss alternate treatments. Patients should not stop taking the medication, as stopping pergolide abruptly can be dangerous.

There are alternative therapies available for Parkinson’s disease, including three other dopamine agonists that have not been associated with valvular heart disease. The removal of pergolide products is not expected to adversely affect patient care because of the alternative therapies available.

“Based on important new drug safety information, FDA has been working with the manufacturers of pergolide products to voluntarily remove these drugs from the market,” said Douglas Throckmorton, M.D., deputy director of FDA’s Center for Drug Evaluation and Research. “The FDA’s increased evaluation of post-market safety is benefiting the public because, in this case, as new data about the product became available, we were able to remove a less safe drug from the market.”

Two recent New England Journal of Medicine studies confirm previous findings associating pergolide with increased chance of regurgitation (backflow of blood) of the mitral, tricuspid, and aortic valves of the heart. Valve regurgitation is a condition in which valves don’t close tightly, allowing blood to flow backward across the valve. Symptoms include shortness of breath, fatigue and heart palpitations.

In light of this additional post-market safety information, the companies that manufacture and sell pergolide will stop shipping pergolide for distribution and, in cooperation with FDA, will withdraw the products from the market.

Permax was approved in 1988 for Eli Lilly and Company as an adjunctive therapy with levodopa in Parkinson’s disease. Valvular heart disease was first described in association with pergolide in 2002. In 2003, FDA asked Lilly to add valvulopathy (abnormality of cardiac valves) to the warnings section of Permax labeling, at which time a Dear Healthcare Practitioner letter was sent by Lilly. In 2006, the warning was upgraded to a black box warning, the FDA’s strongest form of warning, because of new data concerning risks of heart valve damage.

FDA today is issuing a Public Health Advisory (PHA) detailing the removal of pergolide products from the market. The PHA, which is available at www.fda.gov/cder/drug/advisory/pergolide.htm includes information and recommended actions for physicians, pharmacists and patients.

The effect of the voluntary withdrawal on supplies of pergolide currently in pharmacies will not be immediate. This delay will allow time for health care providers and patients to discuss appropriate treatment options and time to change treatments.

FDA is working with the manufacturers of pergolide to determine if it might be possible, once the drug is withdrawn from the market, to make the drug available under an Investigational New Drug Application (IND) for those few patients who are currently receiving pergolide and who cannot be successfully converted to other available treatments.


• From http://clinicaltrials.gov/
 

NIH Clinical Trials, 10 Cushing's studies were found.

1. Recruiting Diagnostic Performance of Screening Tests for Cushing's Syndrome
Condition: Cushing's Syndrome
2. Recruiting Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
3. Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
4. Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
5. Recruiting Genetic Investigation of Pediatric Tumors of the Pituitary Gland
Conditions: Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
6. Recruiting Study of Depression, Peptides, and Steroids in Cushing's Syndrome
Condition: Cushing's Syndrome
7. Recruiting Cognition, Steroids, and Imaging in Cushings Disease
Condition: Cushing Syndrome
8. Not yet recruiting Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing’s Disease
Conditions: Cushing’s Disease
9. Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
10. Recruiting Adolescence, Puberty, and Emotion Regulation
Conditions: Mood Disorder; Neurobehavioral Manifestation; Healthy


Adrenal:

• From  http://www.todaysthv.com/news/news.aspx?storyid=44118

Disease Underlies Hatfield-McCoy Feud

(AP) The most infamous feud in American folklore, the long-running battle between the Hatfields and McCoys, may be partly explained by a rare, inherited disease that can lead to hair-trigger rage and violent outbursts.

Dozens of McCoy descendants apparently have the disease, which causes high blood pressure, racing hearts, severe headaches and too much adrenaline and other "fight or flight" stress hormones.

No one blames the whole feud on this, but doctors say it could help explain some of the clan's notorious behavior.

"This condition can certainly make anybody short-tempered, and if they are prone because of their personality, it can add fuel to the fire," said Dr. Revi Mathew, a Vanderbilt University endocrinologist treating one of the family members.

The Hatfields and McCoys have a storied and deadly history dating to Civil War times. Their generations of fighting over land, timber rights and even a pig are the subject of dozens of books, songs and countless jokes. Unfortunately for Appalachia, the feud is one of its greatest sources of fame.

Several genetic experts have known about the disease plaguing some of the McCoys for decades, but kept it secret. The Associated Press learned of it after several family members revealed their history to Vanderbilt doctors, who are trying to find more McCoy relatives to warn them of the risk.

One doctor who had researched the family for decades called them the "McC kindred" in a 1998 medical journal article tracing the disease through four generations.

"He said something about us never being able to get insurance" if the full family name was used, said Rita Reynolds, a Bristol, Tenn., woman with the disease. She says she is a McCoy descendant and has documents from the doctor showing his work on her family.

She is speaking up now so distant relatives might realize their risk and get help before the condition proves fatal, as it did to many of her ancestors.

Back then, "we didn't even know this existed," she said. "They just up and died."

Von Hippel-Lindau disease, which afflicts many family members, can cause tumors in the eyes, ears, pancreas, kidney, brain and spine. Roughly three-fourths of the affected McCoys have pheochromocytomas, tumors of the adrenal gland.

The small, bubbly-looking orange adrenal gland sits atop each kidney and makes adrenaline and substances called catecholamines. Too much can cause high blood pressure, pounding headaches, heart palpitations, facial flushing, nausea and vomiting. There is no cure for the disease, but removing the tumors before they turn cancerous can improve survival.

Affected family members have long been known to be combative, even with their kin. Reynolds recalled her grandfather, "Smallwood" McCoy.

"When he would come to visit, everyone would run and hide. They acted like they were scared to death of him. He had a really bad temper," she said.

Her adopted daughter, another McCoy descendant, 11-year-old Winnter Reynolds, just had an adrenal tumor removed at Vanderbilt Children's Hospital. Teachers thought the girl had ADHD, attention deficit hyperactivity disorder. Now, Winnter says, "my parents are thinking it may be the tumor" that caused the behavior. "I've been feeling great since they took it out."

Her adoptive father, James Reynolds, said of the McCoys: "It don't take much to set them off. They've got a pretty good temper.

"Before the surgery, Winnter, when we would discipline her, she'd squeeze her fists together and get real angry and start hollering back at us, screaming and crying," he said.

As for the older McCoys, "they just started dropping dead of the tumors," he said. "They didn't know what it was. A name wasn't really put on the disease until 1968. That's when one of my brothers-in-law had to have surgery, to have some tumors removed in his brain. They started to notice tumors occurring in each of the familmembers."

Dr. Nuzhet Atuk at the University of Virginia in Charlottesville and geneticists at the University of Pennsylvania studied the family for more than 30 years, Rita Reynolds said.

"They went back on the genealogy and all of that stuff," she said. "They called it madness disease. They said that it had to be coming from the VHL. Our family would just go off, even on the doctors."

Now 85 and retired, Atuk said he could not talk about his work because of medical confidentiality.

Rita Reynolds had two adrenal tumors removed a few years ago. Her mother and three brothers also had them. So do McCoy descendants in Oregon, Michigan and Indiana, she said.

"When you have these tumors, you're easy to get upset," said Rita's mother, Goldie Hankins, 76, of Big Rock, Va., near the Kentucky-West Virginia border. "When people get on your nerves, you just can't take it. You get angry because your blood pressure was so high."

Still, many are dubious that this condition had much of a role in the bitter feud with the Hatfields, which played out in the hill country of eastern Kentucky and West Virginia for decades.

Some say the feud dates to Civil War days, when some members of the families took opposite sides. It grew into disputes over timber rights and land in the 1870s, and gained more notoriety in 1878, when Randolph or "Old Randal" McCoy accused a Hatfield of stealing one of his pigs. The hostilities left at least a dozen dead.

"The McCoy temperament is legendary. Whether or not we can blame it on genes, I don't know," said Ron McCoy, 43, of Durham, N.C., one of the organizers of the annual Hatfield-McCoy reunion. "There are a lot of underpinnings that are probably a more legitimate source of conflict."

"There was a lot of inter-marrying" that could have played havoc with the gene pool, he conceded.

Another relative, Bo McCoy, of Waverly, Ohio, said he had never heard talk of the disease although he has been diagnosed with a different adrenal gland problem, Cushing's syndrome.

Even Reo Hatfield, who drafted the "truce" the two families famously signed in 2003 to officially end hostilities, doubted the role of the McCoys' disease in the feud.

"I would be shocked" if doctors blamed it on illness, he said.

Altina Waller, a professor of history at the University of Connecticut and author of a book about the feud, agreed.

"Medical folks like to find these kinds of explanations. Like the Salem witchcraft thing. That book came out about how that was caused by wheat that was grown that had this parasite or mold or fungus or something that caused everybody in Salem to go nuts," she said.

"How does it explain the other dozen or so feuds that I've looked at in other places?" she asked, citing disputes over coal and other issues. "The rage and violence as such was not confined to McCoys."

She acknowledges that an argument could be made for seeing the McCoys as the more aggressive of the clans.

"One of the reasons the McCoys don't like me as much in the Tug Valley as the Hatfields do is that I seem to suggest that Randal McCoy, the patriarch of the family, was sort of irrational and flamboyant and did jump to, into wanting violence more than, say, Anderson Hatfield," Waller said.

These days, the "feud" has taken a far more civil tone and all but disappeared, members of both families say. The last time it surfaced was in January 2003. McCoy descendants sued Hatfield descendants over visitation rights to a small cemetery on an Appalachian hillside in eastern Kentucky. It holds the remains of six McCoys, some allegedly killed by the Hatfields.

Copyright 2007 The Associated Press. All rights reserved.




• From  NIH Clinical Trials.  90 Adrenal Studies

 
1. Recruiting Adrenal Function in Critical Illness
Condition: Adrenal Insufficiency
2. Recruiting Catecholamine Reserve and Exercise Tolerance in Healthy Volunteers and Patients With Congenital Adrenal Hyperplasia
Conditions: Congenital Adrenal Hyperplasia; Healthy
3. Recruiting Adrenal Function in Patients With Newly Diagnosed Lung Cancer
Conditions: Lung Cancer; Adrenal Insufficiency
4. Recruiting Hydrocortisone Versus Hydrocortisone Plus Fludrocortisone for the Treatment of Adrenal Insufficiency in Severe Sepsis
Conditions: Sepsis; Adrenal Insufficiency
5. Recruiting Adrenal Function After Living Kidney Donation
Conditions: Addison Disease; Hypoaldosteronism
6. Recruiting Study of Adrenal Gland Tumors
Condition: Adrenal Gland Neoplasm
7. Recruiting Evaluation of 123I-Iodometomidate for Adrenal Scintigraphy
Conditions: Adrenal Mass; Adrenocortical Carcinoma
8. Recruiting Antineoplaston Therapy in Treating Patients With Stage IV Adrenal Gland Cancer
Condition: Adrenocortical Carcinoma
9. Recruiting Natural History Study of Patients With Excess Androgen
Conditions: Excess Androgen; Congenital Adrenal Hyperplasia (CAH); Familial Male-Limited Precocious Puberty (FMPP)
10. Recruiting Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
11. Recruiting Brain Imaging of Childhood Onset Psychiatric Disorders, Endocrine Disorders and Healthy Children
Conditions: Autoimmune Disease; Congenital Adrenal Hyperplasia; Healthy; Mental Disorder Diagnosed in Childhood; Neurologic Manifestations
12. Recruiting Natural History Study of Infants With Adrenal Masses Found on Prenatal and/or Neonatal Imaging
Conditions: Adrenocortical Carcinoma; Brain and Central Nervous System Tumors; Precancerous/Nonmalignant Condition
13. Recruiting The Effects of Case Management in a Medicaid Managed Care Plan
Conditions: Neoplasms; Heart Diseases; Adrenal Cortex Diseases
14. Recruiting Trial in Locally Advanced and Metastatic Adrenocortical Carcinoma Treatment (FIRM-ACT)
Condition: Carcinoma, Adrenal Cortical
15. Recruiting Mutation Analysis of 17α-Hydroxylase
Conditions: Pseudohermaphroditism; Congenital Adrenal Hyperplasia; Hypertension
16. Recruiting ACTH Stimulation and G Protein
Condition: Adrenal Sufficiency
17. Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
18. Recruiting Adrenal and Gonadal Hormone Replacement in Anorexia Nervosa
Condition: Anorexia Nervosa
19. Recruiting German Adrenocortical Carcinoma Registry
Condition: Adrenocortical Carcinoma
20. Not yet recruiting Sunitinib in Refractory Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
21. Recruiting D2 Dopamine Receptor on Human Aldosterone-Producing Adenoma and Its Role in Aldosterone Secretion and Cell Proliferation.
Conditions: Adrenal Aldosterone-Producing Adenoma; Normal Part of the Adrenal Gland
22. Recruiting Tariquidar, Mitotane, Doxorubicin, Vincristine, and Etoposide Plus Surgery in Treating Patients With Recurrent, Metastatic, or Primary Unresectable Adrenocortical Cancer
Condition: Adrenocortical Carcinoma
23. Recruiting Cisplatin-Based Chemotherapy and/or Surgery in Treating Young Patients With Adrenocortical Tumor
Condition: Adrenocortical Carcinoma
24. Recruiting Trial With Taxotere and Cisplatin in Non-Operable Adrenocortical Carcinoma
Condition: Adrenocortical Carcinoma
25. Recruiting Tumor Necrosis Factor in Patients Undergoing Surgery for Primary Cancer or Metastatic Cancer
Conditions: Adrenocortical Carcinoma; Breast Cancer; Colorectal Cancer; Liver Cancer; Melanoma (Skin); Pancreatic Cancer
26. Recruiting Ovarian Follicle Function in Patients With Premature Ovarian Failure
Conditions: Amenorrhea; Hypoaldosteronism; Hypogonadism; Infertility; Premature Ovarian Failure
27. Recruiting Study of Glyceryl Trierucate and Glyceryl Trioleate (Lorenzo's Oil) Therapy in Male Children With Adrenoleukodystrophy
Condition: Adrenoleukodystrophy
28. Not yet recruiting Study of Bile Acids in Patients With Peroxisomal Disorders
Conditions: Infantile Refsum's Disease; Zellweger Syndrome; Bifunctional Enzyme Deficiency; Adrenoleukodystrophy
29. Recruiting Stem Cell Transplant for Inborn Errors of Metabolism
Conditions: Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy; Gaucher’s Disease; Fucosidosis; Wolman Disease; Niemann-Pick Disease; ...
30. Recruiting Clinical Study and Gene Mutation Analysis of Adrenoleukodystrophy in Taiwanese Children
Condition: Adrenoleukodystrophy
31. Recruiting HSCT for High Risk Inherited Inborn Errors
Conditions: Adrenoleukodystrophy; Metachromatic Leukodystrophy; Globoid Cell Leukodystrophy
32. Recruiting Study of Depression, Peptides, and Steroids in Cushing's Syndrome
Condition: Cushing's Syndrome
33. Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
34. Recruiting Ketoconazole and Docetaxel in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
35. Not yet recruiting Post Operative Hemodynamic Function After Anesthetic Induction With Etomidate for Cardiac Surgery With ECC
Condition: Cardiac Surgery
36. Recruiting Endocrine and Psychological Evaluation of Adopted Children
Condition: Psychosocial Adjustment
37. Recruiting Phase II Trial of ZD1839 (Iressa) in Patients With Nonresectable Adrenocortical Carcinoma (ACC)
Condition: Nonresectable Adrenocortical Carcinoma
38. Recruiting Genetic Investigation of Pediatric Tumors of the Pituitary Gland
Conditions: Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
39. Recruiting Cognition, Steroids, and Imaging in Cushings Disease
Condition: Cushing Syndrome
40. Recruiting Kallikrein-Kinin (KKS) and Renin-Angiotensin-Aldosterone System (RAAS) in Primary Aldosteronism
Condition: Hyperaldosteronism
41. Recruiting Diagnostic Performance of Screening Tests for Cushing's Syndrome
Condition: Cushing's Syndrome
42. Recruiting Diagnostic Properties of Aldosterone-Renin Ratio in Primary Aldosteronism Among Hypertensives.
Conditions: Hyperaldosteronism; Hypertension
43. Recruiting The Therapeutic Effect of Bromocriptin in Patients With Primary Aldosteronism
Conditions: Hyperaldosteronism; Hypertension
44. Recruiting Hypothalamic-Pituitary-Adrenal (HPA) Axis in Psychotic Depression
Conditions: Depressive Disorder, Major; Depression; Psychotic Disorders
45. Not yet recruiting Involvement of Endogenous Digitalis-Like Compounds in Breast Cancer
Conditions: Breast Neoplasms; Fibrocystic Disease of Breast; Mammaplasty
46. Recruiting A Study Evaluating the Effects of Lipid Lowering Treatment on Steroid Synthesis
Conditions: Coronary Heart Disease; Diabetes Mellitus; Non-Coronary Atherosclerotic Disease; Hypercholesterolemia
47. Recruiting Maximal Suppression of the Androgen Axis in Clinically Localized Prostate Cancer
Conditions: Cancer; Prostate Neoplasms
48. Recruiting Treatment of Uterine Fibroids With the Selective Progesterone Receptor Modulator CDB-2914
Conditions: Leiomyomata; Uterine Leiomyomata; Fibroids
49. Recruiting Endocrine Studies in Health and Disease
Condition: Endocrine Diseases
50. Recruiting Hydrocortisone in Patients of Out-of-Hospital Cardiac Arrest
Condition: Heart Arrest
51. Recruiting Study to Evaluate the Efficacy and Safety of Oral DHEA Therapy for Postmenopausal Women on Sexual Function, Wellbeing and Vasomotor Symptoms
Conditions: Decreased Libido; Quality of Life; Menopausal Symptoms
52. Recruiting Low-Dose Hydrocortisone in Acutely Burned Patients
Condition: Burns
53. Recruiting Combination of Corticotherapy and Intensive Insulin Therapy for Septic Shock
Condition: Septic Shock
54. Not yet recruiting A Randomized Clinical Trial of Megestrol Acetate as an Appetite Stimulant in Malnourished Children With Cancer
Condition: Malnourished Children With Cancer
55. Recruiting Characterizing Psychological Consequences of Childhood Trauma
Condition: Major Depressive Disorder
56. Recruiting Androgen Deprivation Therapy in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
57. Not yet recruiting Pazopanib After Leuprolide or Goserelin in Treating Patients With Prostate Cancer
Condition: Prostate Cancer
58. Recruiting Bortezomib With or Without Hormone Therapy in Treating Patients With Relapsed Prostate Cancer
Condition: Prostate Cancer
59. Recruiting Ketoconazole, Hydrocortisone, and GM-CSF in Treating Patients With Progressive Prostate Cancer After Hormone Therapy
Condition: Prostate Cancer
60. Recruiting Mineralocorticoid Receptor in the Treatment of Severe Depression
Condition: Major Depression
61. Recruiting Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants
Condition: Neonatal Hypotension
62. Recruiting Hormone Therapy With or Without Docetaxel And Estramustine in Treating Patients With Prostate Cancer That is Locally Advanced or At High Risk of Relapse
Condition: Prostate Cancer
63. Recruiting Cyproterone Acetate in Treating Patients With Newly Diagnosed Stage III or Stage IV Prostate Cancer
Condition: Prostate Cancer
64. Recruiting Hormone Therapy With or Without Squalamine Lactate in Treating Patients Who Are Undergoing a Radical Prostatectomy for Locally Advanced Prostate Cancer
Condition: Prostate Cancer
65. Recruiting Androgen Ablation Therapy With or Without Chemotherapy in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
66. Recruiting Radiation Therapy With or Without Goserelin in Treating Patients Who Have Undergone Surgery for Recurrent or Refractory Prostate Cancer
Condition: Prostate Cancer
67. Recruiting Hormone Therapy and Docetaxel or Hormone Therapy Alone in Treating Patients With Metastatic Prostate Cancer
Condition: Prostate Cancer
68. Recruiting Flutamide With or Without Vaccine Therapy in Treating Patients With Nonmetastatic Prostate Cancer
Condition: Prostate Cancer
69. Recruiting Docetaxel, Radiation Therapy, and Hormone Therapy in Treating Patients With Locally Advanced Prostate Cancer
Condition: Prostate Cancer
70. Recruiting Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer
Condition: Prostate Cancer
71. Recruiting Mifepristone Used to Treat Patients With Non-Psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)
Condition: Depression
72. Recruiting Vaccine Therapy and GM-CSF in Treating Patients With Prostate Cancer That Progressed After Surgery and/or Radiation Therapy
Condition: Prostate Cancer
73. Recruiting Bevacizumab, Hormone Therapy, and Radiation Therapy in Treating Patients With Locally Advanced Prostate Cancer
Condition: Prostate Cancer
74. Recruiting Evaluation of Patients With Endocrine-Related Conditions
Conditions: Endocrine Disease; Glucose Intolerance; Hyperinsulinemia; Impaired Glucose Tolerance; Non Insulin Dependent Diabetes Mellitus; Obesity; ...
75. Recruiting Surgery With or Without Docetaxel and Leuprolide or Goserelin in Treating Patients With High-Risk Localized Prostate Cancer
Condition: Prostate Cancer
76. Recruiting RU-486 in the Treatment of Bipolar Depression
Condition: Bipolar Depression
77. Recruiting Hormone Ablation Therapy, Doxorubicin, and Zoledronate With or Without Strontium 89 in Treating Patients With Androgen-Dependent Prostate Cancer and Bone Metastases
Conditions: Metastatic Cancer; Prostate Cancer
78. Recruiting Androgen Suppression Alone or Combined With Zoledronate, Docetaxel, Prednisolone, and/or Celecoxib in Treating Patients With Locally Advanced or Metastatic Prostate Cancer
Condition: Prostate Cancer
79. Recruiting Diagnosis of Pheochromocytoma
Condition: Pheochromocytoma
80. Recruiting Follow-Up of Patients With Curative-Intent Surgical Resection for NSCLC
Condition: Non-Small Cell Lung Cancer
81. Recruiting Clobetasol Versus Pimecrolimus for Vulvar Lichen Sclerosus
Condition: Lichen Sclerosus
82. Recruiting Pelvic Pain in Women With Endometriosis
Conditions: Endometriosis; Pelvic Pain; Healthy; Tubal Ligation
83. Recruiting Therapy for Children With Neuroblastoma
Condition: Neuroblastoma
84. Recruiting Dexamethasone to Prevent Oral Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
85. Recruiting Effect of LY686017 on Alcohol Craving
Conditions: Alcohol Dependence; Alcoholism
86. Recruiting Rare Genetic Disorders of the Breathing Airways
Conditions: Kartagener Syndrome; Cystic Fibrosis; Pseudohypoaldosteronism; Primary Ciliary Dyskinesia
87. Recruiting Genetic Disorders of Mucociliary Clearance in Nontuberculous Mycobacterial Lung Disease
Conditions: Mycobacteria, Atypical; Cystic Fibrosis; Ciliary Disorders; Pseudohypoaldosteronism; Bronchiectasis
88. Recruiting Positron Emission Tomography (PET) Imaging in Potentially Surgically Resectable Non-Small Cell Lung Cancers (ELPET Trial)
Condition: Non-Small-Cell Lung Carcinoma
89. Recruiting Benefit of Adding Trastuzumab to Second Line Chemotherapy in Breast Cancer Patients Previously Treated With Trastuzumab
Condition: Breast Cancer
90. Recruiting Metabolic Syndrome and Insulin Resistance in Primary Aldosteronism
Condition: Primary Aldosteronism, OGTT


From:


Pituitary:

• From NIH.  85 Pituitary Clinical Trials:
1. Recruiting Genetic Investigation of Pediatric Tumors of the Pituitary Gland
Conditions: Abnormalities; Craniopharyngioma; Cushing's Syndrome; Endocrine Disease; Pituitary Neoplasm
2. Recruiting Study of Thyrotropin-Releasing Hormone in Normal Volunteers and in Patients With Thyroid or Pituitary Abnormalities
Conditions: Healthy; Pituitary Disease; Thyroid Disease
3. Recruiting Evaluation of Patients With Thyroid Disorders
Conditions: Hyperthyroidism; Hypothyroidism; Pituitary Neoplasm
4. Recruiting Effect of Diazoxide on the Obesity Secondary to Hypothalamic-Pituitary Lesions
Conditions: Hypothalamic-Pituitary Lesions; Craniopharyngiomas
5. Recruiting The Treatment and Natural History of Acromegaly
Conditions: Acromegaly; Pituitary Neoplasm
6. Recruiting Effects of Growth Hormone Administration on Cardiovascular Risk in Cured Acromegalics With Growth Hormone Deficiency
Conditions: Acromegaly; Growth Hormone Deficiency; Pituitary Disease
7. Recruiting National Cooperative Growth Study (NCGS) of Optimal Nutropin AQ and Nutropin Dosing in Pubertal Growth Hormone-Deficient (GHD) Patients
Condition: Dwarfism, Pituitary
8. Recruiting Bone Mineral Density (BMD) in Adolescents With Growth Hormone Deficiency (GHD)
Conditions: Dwarfism, Pituitary; Turner Syndrome
9. Recruiting Testosterone Gel Applied to Women With Pituitary Gland Problems
Condition: Panhypopituitarism
10. Recruiting Provocative Testing Using LHRH and hCG of the Pituitary-Gonadal Axis in Persons With Spinal Cord Injury.
Conditions: Spinal Cord Injury; Hypogonadism
11. Recruiting The Effects of Aging and Estrogen on the Brain
Condition: Healthy Postmenopausal Women
12. Recruiting Pituitary Derived-Intermedin is an Estrogen-Modulated Factor for Reducing Blood Pressure
Conditions: Menopause; Hypertension
13. Recruiting Study to Define Optimal IGF-1 Monitoring in Children Treated With NutropinAq
Conditions: Turner Syndrome; Renal Insufficiency, Chronic; Pituitary Diseases; Dwarfism
14. Recruiting Treatment of Adults With Growth Hormone Deficiency
Conditions: Pituitary Disorders; Adult Growth Hormone Deficiency
15. Not yet recruiting Safety and Efficacy of Different Dose Levels of Pasireotide in Patients With de Novo, Persistent or Recurrent Cushing’s Disease
Conditions: Cushing’s Disease
16. Recruiting Efficacy of Octreotide Acetate and Cabergoline in Patients With Acromegaly
Condition: Acromegaly
17. Not yet recruiting Risperidone-Induced Hyperprolactinemia Treated With Bromocriptine
Conditions: Schizophrenia; Hyperprolactinemia
18. Not yet recruiting A Study Investigating a New, Oral Growth Hormone Secretagogue (GHS)(ARD-07) as a Growth Hormone (GH) Stimulation Test
Conditions: Hypopituitarism; Hypothalamic Disease
19. Recruiting Consequence of Lifetime Isolated Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
20. Recruiting Endocrine and Psychological Evaluation of Adopted Children
Condition: Psychosocial Adjustment
21. Recruiting Evaluation and Treatment of Neurosurgical Disorders
Condition: Neurologic Disorders
22. Recruiting Measurement of Outcome of Surgical Treatment in Patients With Acromegaly
Condition: Acromegaly
23. Recruiting Androgen Replacement Therapy in Women With Hypopituitarism
Condition: Hypopituitarism
24. Recruiting Testosterone and Growth Hormone for Bone Loss in Men
Conditions: Hypopituitarism; Hypogonadism; Growth Hormone Deficiency
25. Recruiting Endocrine Dysfunction and Growth Hormone Deficiency in Children With Optic Nerve Hypoplasia
Conditions: Growth Hormone Deficiency; Septo-Optic Dysplasia; Hypopituitarism
26. Recruiting Baseline Sexual Function, Cognitive Function, Body Composition and Muscle Parameters and Pharmacokinetics of Transdermal Testosterone Gel in Women With Hypopituitarism
Condition: Panhypopituitarism
27. Recruiting Canadian Pegvisomant Compassionate Study In Acromegalic Patients
Condition: Acromegaly
28. Not yet recruiting Use of Somatostatin Analogue Therapy as Primary Medical Treatment of Acromegaly
Condition: Acromegaly
29. Recruiting Urinary Aquaporine 2 in Patients With Syndrome of Inappropriate ADH-Secretion Caused by Treatment With Antiepileptic Medicine
Condition: Syndrome of Inappropriate ADH-Secretion
30. Recruiting Estrogen Treatment in Acromegalic Women
Condition: Acromegaly
31. Recruiting Efficacy/Safety of Octreotide Acetate in Patients With Uncontrolled Acromegaly
Condition: Acromegaly
32. Recruiting Growth Hormone and Endothelial Function in Children
Conditions: Growth Hormone Deficiency; Panhypopituitarism; Short Stature
33. Recruiting Lanreotide Autogel and Pegvisomant Combination Therapy in Acromegalic Patients
Condition: Acromegaly
34. Recruiting Pharmacokinetics, Safety and Tolerability of Monthly Doses of Pasireotide Long Acting Release (LAR) Injection in Patients With Acromegaly* and Patients With Carcinoid Disease * Enrollment of Acromegaly Patients Has Already Been Completed
Conditions: Carcinoid Tumor; Acromegaly
35. Not yet recruiting Assessment of the Ability of Subjects With Acromegaly or Their Partners to Administer Somatuline Autogel
Condition: Acromegaly
36. Recruiting Screening Patients With Central Nervous System Tumors for Participation in National Cancer Institute Clinical Trials
Conditions: Brain and Central Nervous System Tumors; Lymphoma
37. Recruiting Acute Side Effects in Patients Who Are Undergoing Stereotactic Radiosurgery for Brain Tumors or Other Brain Disorders
Conditions: Brain and Central Nervous System Tumors; Radiation Toxicity
38. Recruiting Hypothalamic-Pituitary-Adrenal (HPA) Axis in Psychotic Depression
Conditions: Depressive Disorder, Major; Depression; Psychotic Disorders
39. Recruiting Endocrine Studies in Health and Disease
Condition: Endocrine Diseases
40. Recruiting Postmenopausal Women Estrogen and Progesterone Infusion
Conditions: Postmenopause; Aging
41. Recruiting Effects of Ghrelin on the Sleep-EEG and Nocturnal Secretion of Hormones
Conditions: Healthy; Major Depression
42. Recruiting New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Condition: Cushing Syndrome
43. Recruiting Decreased Testosterone Levels in Men Over 65
Conditions: Aging; Hypogonadism; Andropause
44. Recruiting Antineoplaston Therapy in Treating Patients With Brain Tumors
Condition: Brain and Central Nervous System Tumors
45. Recruiting Steady-State Feedback Actions of Testosterone on Luteinizing Hormone Secretion in Young and Older Men
Condition: Hypogonadism
46. Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome; Hereditary Neoplastic Syndrome; Lentigo; Neoplasm; Testicular Neoplasm
47. Recruiting Pulsatile GnRH in Anovulatory Infertility
Conditions: Hypogonadotropic Hypogonadism; Amenorrhea; Polycystic Ovary Syndrome; Kallman's Syndrome
48. Recruiting Hydrocortisone in Patients of Out-of-Hospital Cardiac Arrest
Condition: Heart Arrest
49. Recruiting Effect of Race on Gonadotropin Responses
Condition: Premenopause
50. Recruiting Growth Hormone Treatment of Young Growth Hormone-Deficient Adults
Condition: Growth Hormone Deficiency
51. Recruiting Chromosome 18 Clinical Research Center
Conditions: Chromosome Aberrations; Growth Hormone Deficiency; Delayed Myelination
52. Recruiting The IGFBP-3 Stimulation Test: A New Tool for the Diagnosis of Growth Hormone Deficiency in Children.
Conditions: Short Stature; Growth Hormone Deficiency
53. Recruiting A Phase IV Open-Label Study of Predictive Markers in Growth Hormone Deficient and Turner Syndrome Pre-Pubertal Children Treated With SAIZEN®
Condition: Growth Hormone Deficiency
54. Recruiting Constructing an Insulin-Like Growth Factor-Based Prediction Model
Conditions: Growth Hormone Deficiency; Idiopathic Short Stature; Small for Gestational Age
55. Recruiting Treatment of Children With Insufficient Secretion of Growth Hormone
Condition: Growth Hormone Deficiency (GHD)
56. Recruiting A Study to Evaluate the Dose Response and Safety of PHA-794428 in Adults With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
57. Recruiting A Single Dose Study to Evaluate the PK-PD Response and Safety of PHA-794428 in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
58. Not yet recruiting Sexually Dimorphic Effects of GHRH in Adult Growth Hormone Testing
Condition: Growth Hormone Deficiency
59. Recruiting Effects of Growth Hormone on Glucose and Protein Metabolism in Children With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
60. Not yet recruiting A Multiple Dose Study to Assess Tolerability, Safety and the Pharmacologic Profile of hGH-ViaDerm™ System in Adults With Growth Hormone Deficiency
Condition: Growth Hormone Deficiency
61. Recruiting Cognition, Steroids, and Imaging in Cushings Disease
Condition: Cushing Syndrome
62. Recruiting Characterizing Psychological Consequences of Childhood Trauma
Condition: Major Depressive Disorder
63. Recruiting Exercise Amenorrhea Stress and Bone Health in Adolescents
Condition: Healthy
64. Recruiting Exploratory Clinical Study to Evaluate Sodium Oxybate (Xyrem) on Potential Endocrine Changes
Condition: Narcolepsy With Cataplexy
65. Recruiting Leuprolide in Determining the Cause of Gonadotropin Deficiency
Condition: Hypogonadism
66. Not yet recruiting Neuroendocrine Dysfunction in Traumatic Brain Injury: Correlation With Cognitive Dysfunction and Repair
Condition: Traumatic Brain Injury
67. Recruiting Study of Depression, Peptides, and Steroids in Cushing's Syndrome
Condition: Cushing's Syndrome
68. Recruiting Testosterone-Driven Growth-Hormone (GH) Secretion in Aging Men
Condition: Aging
69. Recruiting Mineralocorticoid Receptor in the Treatment of Severe Depression
Condition: Major Depression
70. Recruiting Study of Recombinant Human Insulin-Like Growth Factor I in Patients With Severe Insulin Resistance
Conditions: Insulin Resistance; Hyperglycemia
71. Recruiting Mifepristone Used to Treat Patients With Non-Psychotic Major Depressive Disorder Referred for Bilateral Electroconvulsive Therapy (ECT)
Condition: Depression
72. Not yet recruiting Involvement of Endogenous Digitalis-Like Compounds in Breast Cancer
Conditions: Breast Neoplasms; Fibrocystic Disease of Breast; Mammaplasty
73. Recruiting Study of GnRH (Gonadotropin Releasing Hormone) Treatment for Idiopathic Hypogonadotropic Hypogonadism (IHH)
Condition: Hypogonadism
74. Recruiting Baselines in Reproductive Disorders
Conditions: Hypothalamic Amenorrhea; Idiopathic Hypogonadotropic Hypogonadism; Polycystic Ovary Syndrome; Acquired Hypogonadotropic Hypogonadism; ...
75. Recruiting RU-486 in the Treatment of Bipolar Depression
Condition: Bipolar Depression
76. Recruiting Investigating the Regulation of Reproductive Hormones in Adult Men
Conditions: Kallmann Syndrome; Hypogonadism; Gonadal Disorder
77. Recruiting Viapaed Study In Children And Adolescents With Asthma
Condition: Asthma
78. Recruiting Obesity and Weight Loss on Reproductive Function
Condition: Obesity
79. Recruiting Adrenal Function in Critical Illness
Condition: Adrenal Insufficiency
80. Recruiting Pelvic Pain in Women With Endometriosis
Conditions: Endometriosis; Pelvic Pain; Healthy; Tubal Ligation
81. Not yet recruiting FHA: Metabolism and Stress Reactivity
Conditions: Anovulation; FHA; Eumenorrhea
82. Recruiting Prospective, Open-Label, Multicenter, International Study of Mifepristone for Symptomatic Treatment of Cushing's Syndrome Caused by Ectopic Adrenal Corticotrophin Hormone (ACTH) Secretion
Condition: Cushing's Syndrome
83. Recruiting Dexamethasone to Prevent Oral Chronic Graft-Versus-Host Disease
Condition: Graft vs Host Disease
84. Recruiting Effect of Lithium Carbonate on Low-Dose Radioiodine Therapy in Early Thyroid Cancer
Conditions: Thyroid Cancer; Differentiated Thyroid Carcinoma
85. Recruiting PACAP38´s Headache Inducing Characteristics and Effects on the Cerebral Blood Flow
Condition: Migraine Without Aura

 


Add your Helpful Hints for Dealing with Cushing's to the website and the email Newsletters.

Newest Bios:
To add or edit your bio, http://www.cushings-help.com/forms/bio.htm
Adrenal Patients
Cindi Cindi has PPNAD (Primary pigmented nodular adrenocortical disease) and has had both adrenal glands removed. Dublin, California
Roxanne (Roxanne) Updated bio

Roxanne was diagnosed with Adrenal Cushing's in 2002 and had an adrenal tumor removed in May of 2003

Gaston, Oregon
Not Yet Diagnosed Patients
Erica (Erica) Erica is not yet diagnosed with Cushing's but she gained over 50 pounds in 6 months. She has had a high UFC and is  being sent to an endocrinologist for further testing. Lawrence, Kansas
Kay (casperslove) Kay has possible Cushing's because of high cortisol and ACTH. She has been diagnosed with PCOS and endometriosis. New Jersey
Peggy (Peggy) Peggy's mom Helen was diagnosed with Cushing's when she was a child, but her doctor advised her she only had a mild case and did not need to be treated. Helen has type 2 Diabetes and has had a pacemaker installed. She recently had a UFC and has been advised that her she is making too much cortisone. Cushing, Oklahoma
Sandra (sncw) Sandra is not yet diagnosed with Cushing's but recently recently read an article in Reader's Digest and recognized herself. She has been diagnosed with premature ovarian failure, hypothyroidism and fibromyalgia Florida
     
Pituitary Patients
Heike (Heike) Updated bio

Heike is from Tallahassee, Florida. Heike has decided to go through another, third, transsphenoidal surgery scheduled for August 22, 2006. Her second pituitary surgery was June 28, 2006. It was not successful and she had to choose between a bilateral adrenalectomy or stereotactic radiation. Her first surgery was in Hamburg, Germany 13 years ago and was exploratory. Heike updated her bio after her third pituitary surgery also done in Hamburg/Germany. She developed Diabetes Insipidus after the last surgery.
Tallahassee, Florida
Iona (iona) Iona has had a tumor on her pituitary removed Dec 2004. May 2006 had radiosurgery on the tumor that reappeared August 2005. She is on a waiting list for a BLA (bilateral adrenalectomy) Salisbury,
United Kingdom
Judi (Cushie Judi) Updated bio
Judi was first diagnosed with Cushing’s 1/12/06, An MRI of the pituitary revealed a hypo-enhancing lesion approximately 5 x 4 x 3 mm. A CT of the adrenal glands in July 2006 was read as normal, but a later CT of the abdomen with contrast demonstrated a possible 1.3 cm low-density lesion in the left adrenal gland.

 Judi updated her bio in April 2007 after her March 21, 2007 pituitary surgery

Batavia, NY
Laura (laurak) Laura was first diagnosed with Cushing's in 1997 and had 1/2 her pituitary removed. She had the rest of her pituitary removed 2 years later when she had a reoccurrence. She has had radiation and has developed hypothyroidism post-secondary to Cushing's Greenfield, Wisconsin
Lindsay (Lindskf) Lindsay had unsuccessful surgery to remove a pituitary tumor and will be having radiation (gamma knife) this week. She is on Ketoconozole to lower her cortisol but doesn't think that is working. Madison, Connecticut
Renae (Renae) Renae is 16 years old and had pituitary surgery December 13, 2006. She recently recently found out that the surgery was unsuccessful and has three different options: redo the surgery, radiation or removal of her adrenal glands (BLA). Swarthmore, Pennsylvania.
Steroid-Induced Patients
     
Kay (casperslove) Kay has possible Cushing's because of high cortisol and ACTH. She has been diagnosed with PCOS and endometriosis. New Jersey
To add or edit your bio, http://www.cushings-help.com/forms/bio.htm

Newest Helpful Doctors:
Dr. Brian Michael
3311 East Murdock
Wichita
Kansas
Phone: 316-689-9989
Dr. Michael has been a tremendous help in diagnosis and treatment of my Cushing's disease. He has gone out of his way to make it right. He knows his stuff and is a great person. Wichita, KS
Brooke Swearingen, MD
Massachusetts General Hospital
15 Parkman Street,
WAC 331
Boston, MA 02114-3117

Phone: (617) 726-3910
Fax: (617) 726-7546
Neurosurgeon

Dr. Swearingen is a gifted and highly skilled neurosurgeon with years of experience in performing transsphenoidal surgery for pituitary tumors. Experience is a key factor in the success of any surgery, but especially important when dealing with tiny microadenomas in the brain. He is a man of few words, but his success rate speaks volumes!
Boston, MA
To add your helpful doctor, http://www.cushings-help.com/forms/doctor.htm

Fundraising:

Support This Site

The Cushing's Store

for all kinds of Cushing's Labeled clothing, US Postage Stamps, Teddy Bears, coffee mugs, totebags and much more. Great for your endo or Secret Someone.

Order Cushing's Awareness Wrist Bands here.


Remember iGive.com...
... all year round.

iGive.com allows online stores to donate a percentage of their profit to running these Cushing's Support sites: the message boards at http://cushings.invisionzone.com/index.php, http://www.cushings-help.com, http://www.cushings-info.com,http://www.cushings-support.com and http://www.cushingsonline.com.

See the list of participating merchants»

===>  FREE $5 DONATIONS!  <===    
Each new member who joins iGive
and shops will earn an additional $5 for the Cushing's Support sites! That's on
top of the standard donations from shopping (up to 26%
of each purchase benefits Cushing's Help and Support!).
Only one hitch: supporters must shop within 45 days of joining to get
the bonus. With over 600 stores now at iGive.com, we have
something for everyone!


Thank you so much for your support.


Upcoming Conventions, Meetings and Seminars:

DC Metro Area, TBA More info as it becomes available.

June 2-5, 2007, ENDO 2007, Toronto, Canada, Metro Toronto Center. More info as it becomes available.

October 6, 2007, Rockford, IL. More info as it becomes available.

• More upcoming local meetings are listed here


Online Chats:

Please join us in the Chat Room TONIGHT at 9 PM Eastern. Click to access through the message boards

If you are not yet a member of the message boards, please use this page: http://cushings.invisionzone.com/chatroom.htm

This room is always open, and has convenient links so that you can get needed information while you're chatting.

I hope to see you tonight!


©2000-2007 Cushing's Help and Support. All rights reserved.
Privacy Policy
Disclaimer